DR. SANJAY KAUL, M.D.
Medical Practice at 3 St, Los Angeles, CA
License number
California A45783
Category
Medical Practice
Type
Specialist
Address
Address
8635 W 3Rd St SUITE 790W, Los Angeles, CA 90048
Phone
(310) 855-8081
(310) 855-0438 (Fax)
(310) 855-0438 (Fax)
Personal information
See more information about SANJAY KAUL at radaris.comName
Address
Phone
4127 Madelia Ave, Sherman Oaks, CA 91403
541 Gerard Ct, Pleasanton, CA 94566
Pleasanton, CA
1324 Winchester Blvd, San Jose, CA 95128
3719 Brockton Dr, Pleasanton, CA 94588
Organization information
See more information about SANJAY KAUL at bizstanding.comSanjay Kaul MD
8700 Beverly Blvd, Los Angeles, CA 90048
Industry:
Cardiologist, Internist
Phone:
(310) 423-4876 (Phone)
Sanjay Kaul
Professional information
Dr. Sanjay Kaul, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
8635 W 3Rd St SUITE 790, Los Angeles 90048
(310) 855-8081 (Phone), (310) 855-0438 (Fax)
8700 Beverly Blvd SUITE 5536, Los Angeles 90048
(310) 423-4876 (Phone), (310) 967-1744 (Fax)
CORDAY MEDICAL GROUP
8635 W 3Rd St SUITE 790W, Los Angeles 90048
(310) 855-8081 (Phone), (310) 855-0438 (Fax)
(310) 855-8081 (Phone), (310) 855-0438 (Fax)
8700 Beverly Blvd SUITE 5536, Los Angeles 90048
(310) 423-4876 (Phone), (310) 967-1744 (Fax)
CORDAY MEDICAL GROUP
8635 W 3Rd St SUITE 790W, Los Angeles 90048
(310) 855-8081 (Phone), (310) 855-0438 (Fax)
Procedures:
Cardiac Imaging, Chest CT (incl. Heart and Lungs)
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1993, Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
8635 W 3Rd St SUITE 790, Los Angeles 90048
8700 Beverly Blvd SUITE 5536, Los Angeles 90048
CORDAY MEDICAL GROUP
8635 W 3Rd St SUITE 790W, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
8700 Beverly Blvd SUITE 5536, Los Angeles 90048
CORDAY MEDICAL GROUP
8635 W 3Rd St SUITE 790W, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
Kashmir University / Government Medical College
Cedars Sinai Med Center
University Iowa Hosps and Clinics
Kashmir University / Government Medical College
Cedars Sinai Med Center
University Iowa Hosps and Clinics
Director, Cardiology Fellowship Training Program At Cedars-Sinai Medical Center
Position:
Director, Cardiology Fellowship Training Program at Cedars-Sinai Medical Center
Location:
Greater Los Angeles Area
Industry:
Hospital & Health Care
Work:
Cedars-Sinai Medical Center
since Jul 1993
-
Director, Cardiology Fellowship Training Program
Education:
University of Kashmir 1978 - 1984
MBBS, Medicine
MBBS, Medicine
Sanjay Kaul, West Hollywood CA
Specialties:
Cardiovascular Disease, Cardiology
Work:
Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
8700 Beverly Blvd, Los Angeles, CA 90048
Education:
Government Medical College, Jammu & Kashmir (1986)
Sanjay Kaul, Los Angeles CA
Specialties:
Cardiologist
Address:
8635 W 3Rd St, Los Angeles, CA 90048
8700 Beverly Blvd, West Hollywood, CA 90048
8700 Beverly Blvd, West Hollywood, CA 90048
Prevention And Treatment Of Restenosis By Local Administration Of Drug
US Patent:
8119590, Feb 21, 2012
Filed:
Sep 27, 2002
Appl. No.:
10/260094
Inventors:
Charles L. Bisgaier - Ann Arbor MI, US
Prediman Krishan Shah - Los Angeles CA, US
Sanjay Kaul - Los Angeles CA, US
Prediman Krishan Shah - Los Angeles CA, US
Sanjay Kaul - Los Angeles CA, US
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
Esperion Therapeutics, Inc - Ann Arbor MI
Esperion Therapeutics, Inc - Ann Arbor MI
International Classification:
A61K 38/00, A61K 47/00, A61K 35/34, A61K 35/44, C07K 2/00, C07K 4/00, C07K 5/00, C07K 14/00, C07K 16/00, C07K 17/00
US Classification:
514 11, 514 12, 424569, 530300
Abstract:
Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally before or during bypass surgery on diseased coronary, peripheral, and cerebral arteries, surgery to implant grafts or transplanted organs, or angioplasty, or to stabilize unstable plaques. In an alternative embodiment, the apolipoprotein is not provided directly, but the gene encoding the apolipoprotein is provided. The gene is introduced into the blood vessel in a manner similar to that used for the protein, where the protein is then expressed. The technique can also be used for delivery of genes for treatment or prevention or restenosis or other cardiovascular diseases. In yet another embodiment, stents are coated with apolipoproteins alone, apolipoproteins formulated with lipids, genetically engineered cells expressing the apolipoproteins, naked DNA coding for an apolipoprotein, or other drugs such as anti-proliferatives for local delivery to an injury site. In a preferred embodiment, the system is used with combination therapy, with for local delivery of an agent such as an apolipoprotein in combination with systemic anti-hypertension therapy, anti-inflammatoy therapy, lipid regulation and/or anti-coagulation therapy.